RxDoctor Payments Data

Richard Martinez, MD

Family Medicine · Redding, CANPI 1578615647

Payments from drug & device makers

$5,583in general payments, 2019–2025

Across 284 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Pfizer$548
  • Lilly USA, LLC$425
  • AbbVie$352
  • GSK$204
  • Novo Nordisk$200
  • plus $2K from 31 others

What the payments were for

  • Food & beverage$5,583100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,583 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$244,247
Medicare patients
831
Services billed
22,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide211$254,611
EliquisApixaban137$171,685
OzempicSemaglutide76$95,000
JardianceEmpagliflozin57$74,759
XareltoRivaroxaban45$57,422
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$49,072
TrulicityDulaglutide26$39,371
XifaxanRifaximin13$38,596
MyrbetriqMirabegron37$32,612
Tadalafil12$24,982
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen519$19,535
Repatha SureclickEvolocumab17$18,591
SynthroidLevothyroxine Sodium186$18,535
EntrestoSacubitril/Valsartan12$15,432
JubliaEfinaconazole11$10,138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$425$293,982237 claims
PfizerEliquis$548$171,685137 claims
Novo NordiskOzempic$200$95,00076 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Tradjenta$123$90,27881 claims
Johnson & JohnsonXarelto$173$57,42245 claims
GSKTrelegy Ellipta$204$49,07243 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$120$38,59613 claims
Astellas Pharma US IncMyrbetriq$63$32,61237 claims
AbbVieSynthroid, Savella$352$23,829197 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Redding

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →